Iqvia

Reimagine clinical development by intelligently iqvia data, technology, and analytics to optimize your trials. The result?

Innovative emerging biopharma and biotech companies are driving the drug development pipeline; competition for funding and resources is fierce. IQVIA Biotech delivers flexible clinical development solutions designed for the specific needs of biotech companies. When you partner with our clinical development team you gain expertise from more than two decades of running clinical trials exclusively for biotech companies, plus access to IQVIA's unparalleled data and technology. We understand the unique challenges and opportunities you face. From drug development strategy to trial design and execution, we draw on this experience to put together the right solution, and the right team, for you. The report provides clarity on the current landscape of EBP companies and their emerging product pipelines, as well as associated clinical trial activity and levels of trial success. In addition, the report focuses on the financial deals, technology and approaches to enable and accelerate these companies' efforts, profiling the drugs these companies have launched or originated, and an assessment of the success of launches in recent years including nuances beyond simply sales uptake.

Iqvia

IQVIA is a provider of biopharmaceutical development, professional consulting and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including investment strategy and management consulting services. IQVIA is the result of the merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider [9] The name of the modern company honors the legacy organizations. IMS Health was best known for its collection of healthcare information spanning sales, de-identified prescription data, medical claims, electronic medical records [10] and social media. Quintiles was the world's largest provider of biopharmaceutical development and commercial outsourcing services. The company offered clinical data management, clinical trial execution services, pharmaceuticals, drug development, financial partnering, and commercialization expertise to companies in the biotechnology, pharmaceutical and healthcare sectors. Throughout its history, the legacy IMS Health's business of collecting anonymized pharmaceutical sales data came under scrutiny from both the media and the legal system. IMS Health v. Ayotte was a free speech case involving IMS Health. Sorrell v. IMS Health Inc. Supreme Court. The High Court ruled in favor of the company. In December , U. Speaking in favor of the FTC, Ramos said, "The FTC has shown that there is a reasonable probability that the proposed acquisition will substantially impair competition in the relevant market and that the equities weigh in favor of injunctive relief.

Flexible clinical solutions for biotech Your milestones. Insight Briefs. New Scientist.

.

We want to help make extraordinary things possible for patients. We are inspired by their stories, and it is our mission to accelerate innovations that enable better outcomes. Every day, we work alongside customers and partners to unleash potential and help improve health around the world. We aim to bring out the best in each other and our diverse expertise. We maximize our positive impact by working together. We are always learning and seeking opportunities for personal, professional, and organizational growth. IQVIA is focused on making intelligent connections for customers across the entire healthcare ecosystem to help you drive healthcare forward. IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise.

Iqvia

Orchestrate your clinical trials with transformative technologies to accelerate innovation, optimize efficiency, and deliver new treatments and vaccines to global markets faster. Molecule to market decisions. C-Suite decisions. Multi-stakeholder decisions. Getting treatments to market is increasingly complex, and market demands never stop growing.

Priceline

Discussion Brief. Lung Cancer Won't Wait. Precision, speed, and scale meet the trust and reliability you need. Net income. Toggle limited content width. Article Talk. Heighten performance, increase efficiencies. Evolving Oncology Endpoints. Spotlight on Biosimilars. Reimagine a smarter, more productive future with an intelligent customer engagement platform that transforms the work of life science teams for real results.

IQVIA is a provider of biopharmaceutical development, professional consulting and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including investment strategy and management consulting services.

San Francisco Business Times. Download as PDF Printable version. April 23, - April 24, Bloomberg News. Improving Decision-Making through Connected Intelligence. Dedicated to your success. Supreme Court. The Global Use of Medicines Copy Link. In addition, the report focuses on the financial deals, technology and approaches to enable and accelerate these companies' efforts, profiling the drugs these companies have launched or originated, and an assessment of the success of launches in recent years including nuances beyond simply sales uptake. Email Us Get in touch today to discover the right solutions for you.